History

history

XCELL
THERAPEUTICES
  • 2021

    • 10

      Innovative Meritorious Technology Firm
      Award (Ministry of SMEs and Startups)

    • 07

      Ministry of SMEs and Startups Pre-unicorn

    • 05

      New Excellent Product (NEP) Nomination

    • 03

      Attract Series C Funding

    • 02

      Technology Assessment Grade (A, BBB)

  • 2020

    • 12

      Certification of Family-friended Firm (Ministry of Gender Equality and Family)

    • 10

      Viral Transport Medium (VTM) Development

    • 10

      Cell Therapy Bioprocessing Excellence of the year (IMAPAC)

    • 09

      Bio Innovation Growth Company Nomination (For startups) Ministry of Trade,
      Industry and Energy

    • 08

      Yongin Facility FDA 510(k) Listed

    • 02

      The certification of Excellent Technology
      Evaluation Company (TI-3)

    • 02

      Certification of local component and material firm

  • 2019

    • 12

      White Labeled Contract concluded with Multinational Firm

    • 07

      Series B Funding

    • 06

      Yongin GMP facility operation

    • 05

      CellCor CD MSC Development

  • 2018

    • 12

      Series A Funding

    • 09

      The certification of Excellent Technology
      Evaluation Company (TI-3)

    • 06

      South Korean Ministry of Trade,
      Industry and Energy Cell Media R&D Project

    • 01

      TIPS Commercializing Project fund Contracted
      (Tech Incubator Program for Startup)

  • 2017

    • 10

      Designated R&D for the exception of Military Service

    • 09

      Securement Greenfield in Chungbuk Osong Bio-Hub Complex

    • 06

      Startup Research and Development creative Economy Project
      (Ministry of SMEs and Startups)

    • 03

      Middle Company Networking Research Development Project
      (Ministry of SMEs and Startups)

  • 2016

    • 12

      Advancing Medical Care Research and Development Project
      (Ministry of Health and Welfare)

    • 11

      CellCor™ SFD MSC Development

    • 11

      Industry University Industrial Project (Ministry of SMEs and Startups)

    • 07

      Perform Research and Development Project
      (Ministry of Trade, Industry and Energy)

    • 06

      Venture Company Approval (Kibo)

  • 2015

    • 12

      Patent Acquisition (Korea 3, Overseas 2)

    • 11

      Company R&D Approval (KOITA)

    • 09

      Xcell Therapeutics, established